| Scorecard |
|---|
|
3 / 5 Stars
|
|
Lipper
4
2
1
4
2
|
|
Zacks Investment Research
3
(Hold)
|
|
Standard & Poor's
2 / 5 Stars
|
|
TheStreet.com
E+
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 2.54 | 2.54 |
| Stocks | 53.26 | 53.26 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 44.2 | 44.2 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 04.30.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 04.30.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Nektar Therapeutics, Inc. | NKTR | 24.56 | 9.31 |
| Advanced Micro Devices Inc | AMD | 65.0 | 3.22 |
| Nokia Oyj | NOK1V | --- | 3.07 |
| Fairchild Semiconductor International Inc | FCS | -0.35 | 2.45 |
| Electrocomponents PLC | ECM | --- | 2.41 |
| Coherent, Inc. | COHR | 15.2 | 2.34 |
| Cepheid | CPHD | -0.12 | 2.32 |
| Carl Zeiss Meditec AG | CZMWF | 2.92 | 2.21 |
| Urban Outfitters Inc. | URBN | 6.35 | 2.21 |
| Seattle Genetics, Inc. | SGEN | 51.4 | 2.11 |
